logo

For the Inventor, By the Inventor

Chestnut Ridge, NY, United States of America

Par Pharmaceutical, Inc.


USPTO Granted Patents = 43

% Expired Patents = 16.3


Trademarks = 3

Forward Citations = 241

Loading Chart...
Loading Chart...

32 inventors (with patents filed for the assignee):

goldMedal Vinayagam Kannan (23 out of 23 patents)

silverMedal Matthew Kenney (20 out of 22 patents)

bronzeMedal Suketu Sanghvi (19 out of 30 patents)

4.  Sunil Vandse (17 out of 20 patents)

5.  Anthony P Sileno (7 out of 18 patents)

6.  Zenaida Go (7 out of 11 patents)

7.  Steven C Quay (7 out of 94 patents)

8.  Satish Shamlal Patil (5 out of 5 patents)

9.  Peter C Aprile (4 out of 6 patents)

10.  Robert Ruemer (4 out of 4 patents)

11.  Narayan Ragunathan (4 out of 7 patents)

12.  Robert A Femia (4 out of 8 patents)

13.  Mohankumar Lakshmanan (4 out of 4 patents)

14.  Selvakumar Viruthagiri (4 out of 4 patents)

15.  Somasundaram Muthuramalingam (4 out of 4 patents)


Core Competencies:
Vasopressin Formulations
Epinephrine Formulations
Varenicline Compound
Sugammadex Pre-filled Syringe
Cyanocobalamin Formulations
Intranasal Delivery
Nasal Calcitonin Formulations
Chlorobutanol
Hypotension Treatment
Cyanomethyl Ester Precursors
Data Sorting Methods

43 patents:

1. 12186362 - Vasopressin formulations for use in treatment of hypotension (2025-01-07),
2. 11872234 - Vareniciline compound and process of manufacture thereof (2024-01-16),
3. 11779587 - Vareniciline compound and process of manufacture thereof (2023-10-10),
4. 11717524 - Varenicline compound and process of manufacture thereof (2023-08-08),
5. 11602537 - Varenicline compound and process of manufacture thereof (2023-03-14),
6. 11337938 - Epinephrine formulations (2022-05-24),
7. 11207372 - Vasopressin formulations for use in treatment of hypotension (2021-12-28),
8. 11135265 - Vasopressin formulations for use in treatment of hypotension (2021-10-05),
9. 11097023 - Pre-filled syringe containing sugammadex (2021-08-24),
10. 10920278 - Method to treat hypotension using vasopressin in certain genotypes (2021-02-16),
11. 10844435 - Method to treat hypotension using vasopressin in certain genotypes (2020-11-24),
12. 10624864 - Epinephrine formulations (2020-04-21),
13. 10130592 - Epinephrine formulations (2018-11-20),
14. 10010575 - Vasopressin formulations for use in treatment of hypotension (2018-07-03),
15. 9993520 - Vasopressin formulations for use in treatment of hypotension (2018-06-12),
PAR Pharmaceutical, Inc. is a leading global specialty pharmaceutical company that develops, manufactures, and markets high-quality and affordable generic drugs. With a diverse product portfolio, PAR focuses on providing innovative solutions to improve patient access to essential medications. The company is dedicated to upholding the highest standards of quality, safety, and reliability in all its operations.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Par Pharmaceutical, Inc.
43 Patents

#2 in Chestnut Ridge, NY

#497 in New York

#8,076 in US

#15,994 in the World

Chestnut Ridge, NY (US)
Chestnut Ridge, NY, United States of America

Par Pharmaceutical, Inc.

Forward Citations = 241

32 inventors:

goldMedal Vinayagam Kannan (23 out of 23 patents)

silverMedal Matthew Kenney (20 out of 22 patents)

bronzeMedal Suketu Sanghvi (19 out of 30 patents)

4.  Sunil Vandse (17 out of 20 patents)

5.  Anthony P Sileno (7 out of 18 patents)

Please report any incorrect information to [email protected]
Loading…